KROS
Keros TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
KROS vs peer average
52/100
KROS vs. peer average (C vs. C)
Grade spread
A 1 · B 3 · D 2 · F 2
Graded peers loaded
Coverage
9 graded
90% of tracked
Peer overview
CRSP is the first available peer comparator.
Clinical-stage biotech with multiple programs; similar risk profile for development-stage catalysts.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KROS
Keros Therapeutics
CRSP
CRISPR Therapeutics
Grade
C
B
Momentum
13
40
Value
54
41
Sentiment
100
86
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs CRSP
KROS / CRSP
Grade Position
In line
KROS vs. peer average (C vs. C)
52/100
Momentum
13
CRSPValue
54
KROSSentiment
100
KROSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KROS
CRSP is the first peer returned for this comparison set.